Rebecca Kraus
Physician Assistant · Davidson, NCNPI 1427301027
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $315,037 of the $425,014 with a category attached, or 74.1%. Neurocrine Biosciences, Inc. accounts for 61.8% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $214,277, more than ten times the $4,334 reported in 2021. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,685 payments — averaging $252.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$263K
- Axsome Therapeutics, Inc.$129K
- Alkermes, Inc.$14K
- Supernus Pharmaceuticals, Inc.$5K
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $10K from 31 others
What the payments were for
- Consulting fees$46,12511%
- Speaking & faculty fees$315,03774%
- Travel & lodging$37,3689%
- Food & beverage$26,2816%
- Education$2030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$425,014 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 13 | $9,967 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 22 | $787 |
| Duloxetine Hcl | 34 | $615 |
| Lamotrigine | 37 | $591 |
| Bupropion XlBupropion Hcl | 12 | $572 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $551 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $264 |
| Citalopram HbrCitalopram Hydrobromide | 19 | $237 |
| Clonazepam | 33 | $223 |
| Trazodone Hcl | 41 | $202 |
| Aripiprazole | 11 | $180 |
| Olanzapine | 20 | $155 |
| Fluoxetine Hcl | 14 | $114 |
| Sertraline Hcl | 21 | $75 |
| Mirtazapine | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $807 | $9,96713 claims |
| Almatica Pharma LLCSertraline Hcl | $207 | $7521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Davidson
- Benjamin EpsteinDavidson$447K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
- Meghan EmigCharlotte$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.